Lenvima fda approval date?

When did Lenvima (lenvatinib) get FDA approval?

Lenvima (lenvatinib) was first approved by the FDA on February 13, 2015 for advanced radioactive iodine-refractory differentiated thyroid cancer (DTC). [1]

Was it approved on the same date for other cancers?

No. Lenvima later received additional FDA approvals for other indications (each with its own approval date), but the initial FDA approval date for the drug is February 13, 2015. [1]

Where can I verify Lenvima’s approval date?

A record for Lenvima’s regulatory history (including the initial FDA approval date) is available via DrugPatentWatch.com. [1]

Sources

[1] https://www.drugpatentwatch.com/p/lenvima